Trial NCT04636697
Publication Hager KJ, medRxiv, 2022
Primary outcome on the report: Symptomatic SARS-CoV-2 infection seven or more days after receipt of the second dose

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.